Maura M.
- Country
- Italy
- Department
- S.C. Pediatria Oncologica
Research Overview
- Phase 2 Randomized Study of Radiotherapy with Nimotuzumab and Vinorelbine in Pediatric Diffuse Intrinsic Pontine Glioma
- Evaluation of Levothyroxine for TSH Suppression to Mitigate Radiation-Induced Hypothyroidism in Medulloblastoma and Pediatric Lymphoma Patients
- Evaluation of Ponatinib in Pediatric Patients with Recurrent or Refractory Leukemias, Lymphomas, and Solid Tumors: A Phase 1/2 Open-Label Study
Data & Insights
Has run more than one trial at 123 of 171 partner sites.
Specializations
Neuro-Oncology Focus
This investigator specializes in treating various types of pediatric brain tumors, with particular emphasis on ependymoma and medulloblastoma. Their research extends to complex cases like diffuse intrinsic pontine glioma (DIPG), addressing challenging pediatric central nervous system malignancies.
- Intracranial and Spinal Tumors
- Advanced Brain Cancer Therapeutics
- Pediatric Neurological Malignancies
Hematologic Oncology
The investigator focuses on treating recurrent and refractory leukemias and lymphomas in pediatric patients. Their work includes innovative approaches to both Hodgkin and non-Hodgkin lymphomas, particularly in cases requiring specialized radiation therapy protocols.
- Advanced Leukemia Treatment
- Lymphoma Management
- Targeted Therapy Applications
Radiation Oncology
Their expertise encompasses radiation therapy optimization for pediatric cancers, including research into preventing radiation-induced hypothyroidism. The investigator develops specialized protocols combining radiation with targeted therapies like nimotuzumab and vinorelbine.
- Protective Radiation Strategies
- Combined Modality Treatment
- Radiation-Related Complications
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.